Close Menu

NEW YORK (GenomeWeb) – Roche announced today the inclusion of its Cobas HIV-1/HIV-2 nucleic acid test in its Global Access Program.

The CE-marked test enables health professionals to distinguish between HIV-1 and HIV-2 and provides users flexible PCR testing with serum, plasma, and validated dried blood spot (DBS) collection card sample types to improve treatment options based on subtype infections in rural locations, Roche said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.